News & Updates

Show Multimedia Only

HDL-C a potential marker of functional outcome in ischaemic stroke

12 Feb 2026

Elevated concentrations of high-density lipoprotein cholesterol (HDL-C) are associated with favourable functional recovery in patients with ischaemic stroke, as suggested in a recent study.

HDL-C a potential marker of functional outcome in ischaemic stroke

12 Feb 2026

People with evening chronotype may have poorer heart health

11 Feb 2026 by

Middle aged or older people with an evening chronotype are at increased risk of cardiovascular disease (CVD), owing to their unfavourable cardiovascular health profile, according to a study.

People with evening chronotype may have poorer heart health

11 Feb 2026

Hypertension ups risks of adverse outcomes, fibrosis progression in MASLD

11 Feb 2026

Patients with metabolic dysfunction-associated steatotic liver disease (MASLD), who also happen to have hypertension, are at much greater risk of adverse clinical outcomes and progression of liver stiffness and fibrosis, according to a study.

Hypertension ups risks of adverse outcomes, fibrosis progression in MASLD

11 Feb 2026

Novel balloon-expandable valve shows encouraging results in pooled analysis

10 Feb 2026 by

A pooled analysis of first-in-human and early feasibility studies demonstrates promising 30-day clinical and echocardiographic outcomes with the novel DurAVR transcatheter heart valve (THV) in patients with small aortic annuli (SAA).

Novel balloon-expandable valve shows encouraging results in pooled analysis

10 Feb 2026

Novel NPR-1 agonist no better than placebo for treatment of resistant hypertension

09 Feb 2026

Treatment with the novel natriuretic peptide receptor-1 (NPR-1) agonist XXB750 demonstrates a neutral effect on 24-h ambulatory systolic blood pressure (SBP) in patients with resistant hypertension, as shown by the results of a phase II trial.

Novel NPR-1 agonist no better than placebo for treatment of resistant hypertension

09 Feb 2026

Low SBP does not raise risk of all-cause mortality, CV events

08 Feb 2026

Blood pressure (BP) shows a linear association with several cardiovascular (CV) and renal outcomes in patients with type 2 diabetes (T2D), reveals a study.

Low SBP does not raise risk of all-cause mortality, CV events

08 Feb 2026

CAD incidence lower in HCM vs non-HCM patients

07 Feb 2026

Patients with hypertrophic cardiomyopathy (HCM) undergoing computed tomography angiography (CTA) for table chest pain enjoy a lower incidence of obstructive coronary artery disease (CAD) and show more stable coronary plaque features than those with no HCM, reveals a study.

CAD incidence lower in HCM vs non-HCM patients

07 Feb 2026

Delays in hypertension diagnosis persist despite records of high BP measurement

06 Feb 2026

A recent study has observed delays in hypertension diagnosis, which potentially results in hospital visits and other cardiovascular diagnoses.

Delays in hypertension diagnosis persist despite records of high BP measurement

06 Feb 2026

Native vessel vs SVG PCI: Which procedure is more effective?

04 Feb 2026

Percutaneous coronary intervention (PCI) of the saphenous vein graft (SVG) results in improvements in 1-year clinical outcomes relative to native vessel PCI, reports a study.

Native vessel vs SVG PCI: Which procedure is more effective?

04 Feb 2026

Nocturnal hypertension tied to poorer cardiovascular outcomes among seniors

03 Feb 2026

Among patients of very advanced age, those with nocturnal hypertension are at increased risk of adverse cardiovascular outcomes, as reported in a study.

Nocturnal hypertension tied to poorer cardiovascular outcomes among seniors

03 Feb 2026

News & Updates

Showing Cardiology articles

Showing

Specialty:

HDL-C a potential marker of functional outcome in ischaemic stroke

HDL-C a potential marker of functional outcome in ischaemic stroke

People with evening chronotype may have poorer heart health

People with evening chronotype may have poorer heart health

Hypertension ups risks of adverse outcomes, fibrosis progression in MASLD

Hypertension ups risks of adverse outcomes, fibrosis progression in MASLD

Novel balloon-expandable valve shows encouraging results in pooled analysis

Novel balloon-expandable valve shows encouraging results in pooled analysis

Novel NPR-1 agonist no better than placebo for treatment of resistant hypertension

Novel NPR-1 agonist no better than placebo for treatment of resistant hypertension

Low SBP does not raise risk of all-cause mortality, CV events

Low SBP does not raise risk of all-cause mortality, CV events

CAD incidence lower in HCM vs non-HCM patients

CAD incidence lower in HCM vs non-HCM patients

Delays in hypertension diagnosis persist despite records of high BP measurement

Delays in hypertension diagnosis persist despite records of high BP measurement

Native vessel vs SVG PCI: Which procedure is more effective?

Native vessel vs SVG PCI: Which procedure is more effective?

Nocturnal hypertension tied to poorer cardiovascular outcomes among seniors

Nocturnal hypertension tied to poorer cardiovascular outcomes among seniors